Raymond James Financial started coverage on shares of PTC Therapeutics (NASDAQ:PTCT – Get Free Report) in a report released on Friday. The firm set an “outperform” rating and a $108.00 price target on the biopharmaceutical company’s stock. Raymond James Financial’s target price suggests a potential upside of 52.43% from the company’s previous close. Other research […]

Raymond James Financial upgraded shares of Third Coast Bancshares (NASDAQ:TCBX – Free Report) from a market perform rating to an outperform rating in a research report released on Tuesday, Marketbeat.com reports. The brokerage currently has $45.00 price target on the stock. A number of other analysts have also recently commented on the stock. Keefe, Bruyette […]

Raymond James Financial upgraded shares of ARM (NASDAQ:ARM – Free Report) from a market perform rating to an outperform rating in a research report sent to investors on Wednesday morning, Marketbeat Ratings reports. Raymond James Financial currently has $166.00 price target on the stock. A number of other equities research analysts have also issued reports […]